Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Cancer

Explore clinical trials studying Head and Neck Cancer. Study availability and eligibility vary by location and protocol.

1,158 public trials 213 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Cancer trial results

Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

NCT05608876

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations
  • The Kinghorn Cancer Centre Sydney, New South Wales, Australia
  • Metro South Hospital and Health Service, via the Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Cardiff and Vale University Health Board - University Hospital of Wales (UHW) Cardiff, United Kingdom
  • East and North Hertfordshire NHS Trust (Incorporating Mount Vernon Cancer Centre) of Lister Hospital Stevenage, Hertfordshire, United Kingdom
View Trial Details
Active, Not Recruiting

Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

NCT04675333

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Hoag Hospital Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
  • Cedar Sinai Medical Center Los Angeles, California, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

NCT04675294

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Hoag Hospital Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
View all 53 locations
View Trial Details
Active, Not Recruiting

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

NCT04609280

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +14 more
Locations
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • UMMC Baltimore, Maryland, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Upper Chesapeake Health Bel Air, Maryland, United States
View Trial Details
Active, Not Recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations
  • City of Hope Duarte, California, United States
  • Northwell Health Manhasset, New York, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details

Related conditions